Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime—up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks.
WebinarsView All Webinars >
Attendees learn how Resistance Associated Variants (RAV) affect Hepatitis C Virus treatment, understand what clinical trials tell us about resistance testing, and learn how to... Read more
Dr. McClure defines the fundamentals and limitations of presumptive and definitive drug testing methods, discusses prescription and illicit opioid drug metabolism and reviews interpretation of... Read more
Dr. John Leake discusses the epidemiology of Zika virus, including co-circulating viruses transmitted by Aedes aegypti mosquito, the clinical features of Zika virus and special... Read more
Expert InsightsView All Expert Insights >
PublicationsView All Publications >
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Bandino JP, Kazlouskaya V, Ergin S, Moles-Proveda P, Cleaver NJ, Kabigting FD, Shackelton JB, Thieu K
J Cutan Pathol 2015
Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Burger H, Weiser B, Gao W, Anastos K, Young M
AIDS Res Ther 2015;12:11
Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Brauer JA, Kazlouskaya Y, Alabdulrazzaq H, Bae YS, Bernstein LJ, Anolik R, Geronemus RG
JAMA Dermatol 2015;151:278-284